| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/1999 | EP0928294A1 Method and apparatus for preparing an acellular red blood cell substitute |
| 07/14/1999 | EP0928290A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928202A1 Non-invasive administration of adeno-associated viral vectors |
| 07/14/1999 | EP0928200A2 Therapeutic combinations of rar antagonists and rxr agonists |
| 07/14/1999 | EP0928198A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/14/1999 | EP0928196A1 Beta-glucan products and extraction processes from cereals |
| 07/14/1999 | EP0928195A1 Compositions for use in embolizing blood vessels |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0928193A1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| 07/14/1999 | EP0928192A1 Antimycotic gel with high active substance release |
| 07/14/1999 | EP0928191A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 07/14/1999 | EP0928190A2 Nucleic acid particle delivery |
| 07/14/1999 | EP0928187A1 Antibacterial composition |
| 07/14/1999 | EP0928185A1 Compositions and uses thereof |
| 07/14/1999 | EP0928184A1 Anti-caries oral compositions |
| 07/14/1999 | EP0928183A2 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis |
| 07/14/1999 | EP0820772A4 Immunomodulating medicinal agent |
| 07/14/1999 | EP0804179B1 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/14/1999 | EP0777649B1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor agonists |
| 07/14/1999 | EP0770080B1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
| 07/14/1999 | EP0748210B1 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles |
| 07/14/1999 | EP0735892B1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate |
| 07/14/1999 | EP0730591B1 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 07/14/1999 | EP0721336B1 Benzazole compounds for use in therapy |
| 07/14/1999 | EP0665833B1 Dopamine receptor subtype ligands |
| 07/14/1999 | EP0658161B1 Substituted thiazolidinedione derivatives |
| 07/14/1999 | EP0648205B1 Peptidyl derivatives as metalloproteinase inhibitors |
| 07/14/1999 | EP0619729B1 Composition to help stop smoking |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | CN1222912A Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 07/14/1999 | CN1222911A Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 07/14/1999 | CN1222910A 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 07/14/1999 | CN1222909A Pyrazinone thrombin inhibitors |
| 07/14/1999 | CN1222907A Azetidinone derivatives for treatment of atheroscleroses |
| 07/14/1999 | CN1222905A New synthetic catechol derivatives, method for production and use thereof |
| 07/14/1999 | CN1222859A Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 07/14/1999 | CN1222855A Ionic polymers as anti-infective agents |
| 07/14/1999 | CN1222854A Cosmetic compositions |
| 07/14/1999 | CN1222853A Use of phosphonic acid esters for treatment of functional disorders of brain and depression |
| 07/14/1999 | CN1222852A Nasal spray containing intranasal steroid and antihistamine |
| 07/14/1999 | CN1222851A Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 07/14/1999 | CN1222850A Therapeutic treatment for VEGF related occular diseases |
| 07/14/1999 | CN1222524A Carbohydrate derivatives |
| 07/14/1999 | CN1222521A 1,3,8-triaza-spiro [4,5] decan-4-on derivatives |
| 07/14/1999 | CN1222516A Naphth oxazines derivvs., process for their preparation and pharmaceutical compositions containing them |
| 07/14/1999 | CN1222514A Imidazole derivative and medicine comprising same as active ingredient |
| 07/14/1999 | CN1222510A Arylacetic amide derivative or salt thereof, and pharmaceutical comprising it |
| 07/14/1999 | CN1222509A New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1999 | CN1222387A Lotion for treating anal fistula and gynopathy |
| 07/14/1999 | CN1222377A Hypertension ointment for external use |
| 07/14/1999 | CN1222369A Compound asthma capsule and its preparation |
| 07/14/1999 | CN1222367A Preparation of medicine for curing burns and scalds |
| 07/14/1999 | CN1222356A New application of angelic polysaccharide and angelic lactone as biological reaction regulator to cure tumor |
| 07/14/1999 | CN1222351A Compound nose drop |
| 07/14/1999 | CN1222350A Medicine composition for odinopoenia of long pregnancy |
| 07/14/1999 | CN1222349A Brain nourishing composition |
| 07/14/1999 | CN1222348A Memory strengthening medicine |
| 07/14/1999 | CN1222347A Emulsion type nose spray |
| 07/14/1999 | CN1044118C 7-Isoindolinyl-quinolone derivatives and its preparation |
| 07/14/1999 | CN1044117C Compound for inhibition of HIV protease, its preparing method and its drug use |
| 07/14/1999 | CN1044116C Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action and use thereof |
| 07/14/1999 | CN1044092C Antigen-antibody-recombination DNA composite type vaccin |
| 07/14/1999 | CN1044089C Medicine composition with enantiomerically pure beta-D-dioxolane nucleosides as active component |
| 07/14/1999 | CN1044088C Pharmaceutical composition for oral use and method of preparing them |
| 07/13/1999 | US5922907 A chemical intermediate phenylglycyl hydroxyethyl ester or 4-phenylglycyl hydroxyethyl ester |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922879 N-aminoalkyl-2-anthraquinonecarboxamides: new dopamine receptor subtype specific ligands |
| 07/13/1999 | US5922877 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 07/13/1999 | US5922876 Preparation of oxymorphone from morphine |
| 07/13/1999 | US5922875 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 07/13/1999 | US5922872 Bactericides and drugs |
| 07/13/1999 | US5922868 1-(4,4-ethylenedioxy-3-methylpentyl)-3-methyl-7-propylxanthine |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922775 Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity |
| 07/13/1999 | US5922773 Treatment with n-methyl-d-aspartate antagonist for vision defects |
| 07/13/1999 | US5922772 Therapeutic substituted guanidines |
| 07/13/1999 | US5922770 Novel compounds that stimulate the release of growth hormone from the pituitary |
| 07/13/1999 | US5922769 Treating hyperglycemia with an oral hypoglycemic agents |
| 07/13/1999 | US5922768 Mixture of bactericide, water soluble polyethylene glycol and perfume |
| 07/13/1999 | US5922766 Palatable elemental medical food |
| 07/13/1999 | US5922765 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922760 Agent for prevention or alleviation of allergy symptoms |
| 07/13/1999 | US5922758 Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage |
| 07/13/1999 | US5922757 Administering alpha-tocopherol to patients with hepatitis c who are refractory to interferon |
| 07/13/1999 | US5922756 Treating chronic and acute inflammatory conditions |
| 07/13/1999 | US5922754 Pharmaceutical compositions containing paclitaxel |
| 07/13/1999 | US5922753 Methods for treating bone deficit conditions with benzothiazole |
| 07/13/1999 | US5922750 Terpenoidic derivatives useful as antitumor agents |
| 07/13/1999 | US5922749 Administering to a human or animal the drug ondansetron (r-1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)m ethyl)-4h-car bazol-4-one) or a physiologically acceptable salt or solvate |
| 07/13/1999 | US5922748 Indole derivatives as 5-HT agonists |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922746 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 07/13/1999 | US5922741 5-aminopyrazoles useful as tyrosine kinase inhibitors |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922739 Antiischemic agents |
| 07/13/1999 | US5922736 Chronic, bolus administration of D-threo methylphenidate |